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Objectives: Upon completion of this article, the reader will be
able to describe the pathophysiology, diagnosis, and treat-
ment options of high-flow priapism.
Accreditation: This activity has been planned and imple-
mented in accordancewith the Essential Areas and Policies of
the Accreditation Council for Continuing Medical Education
(ACCME) through the joint providership of Tufts University
School of Medicine (TUSM) and Thieme Medical Publishers,
New York. TUSM is accredited by the ACCME to provide
continuing medical education for physicians.
Credit: Tufts University School of Medicine designates this
journal-based CME activity for a maximum of 1 AMA PRA
Category 1 Credit™. Physicians should claim only the credit
commensurate with the extent of their participation in the
activity.
Priapism is defined as complete or partial penile tumescence
that continues for more than 4 hours beyond sexual stimulation
or is entirely unrelated to sexual stimulation.1–3 It is a complex
medical emergencywithvaried pathophysiology, usually requir-
ing prompt medical, and sometimes surgical, management to
prevent complications such as irreversible erectile dysfunction.2
The name priapism is derived from Priapus, the ancient Greek
god of fertility. Mythological tales describe the cursing of the
unborn Priapus while in Aphrodite’s womb, an act of vengeful
spitefulness by the goddess Hera, which left the unfortunate
child with enormous over-sized genitalia and an outcast from
MountOlympus. His imagewas adopted as a symbol of fertility.4
The first reported case of priapism in the English medical
literature was published in the Lancet by Tripe in 1845.5
Subsequently in 1914, Frank Hinman Sr. published a land-
mark article describing the natural history of priapism.6 Later
in 1960, Frank Hinman Jr. proposed that venous stasis,
increased blood viscosity, and ischemia were responsible
for priapism, and he emphasized that failure to correct these
abnormalities in the penile environment was the primary
cause for treatment failures.7
Currently, priapism remains a common reason for many
men to be seen in the emergency department. In fact,
between 2006 and 2009, it is estimated that there were
32,462 visits made to emergency departments in the United
States for priapism. This represents a national incidence of
5.34 per 100,000 men per year.2 For clinical management,
priapism can be stratified into three groups: low-flow pria-
pism (ischemic, veno-occlusive), stuttering priapism (inter-
mittent), and high-flow priapism (nonischemic, arterial).1,2
Anatomy and Physiology of Normal Penile
Erection
The penis consists of three longitudinally oriented bodies or
corpora. The dorsolaterally located paired corpora cavernosa
are surrounded by the thick tunica albuginea and consist of
multiple smooth muscle and endothelial-lined sinusoids,
which are capable of significant volume expansion with









Abstract Priapism is prolonged erection that persists beyond or is unrelated to sexual stimulation.
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spongiosum is enveloped by a thinner layer of tunica albu-
ginea and surrounds the penile urethra, extending distally to
form the glans penis. The penis is supplied by the penile
artery, which is a branch of the internal pudendal artery,
which in turn arises from the anterior division of the internal
iliac artery. The penile artery divides into three branches: the
bulbar artery (to the corpus spongiosum), the dorsal artery,
and the cavernosal artery (main blood supply to the erectile
tissue of the corpus cavernosum).4
In the flaccid penis, the high resting tone of the cavernosal
arterioles and sinusoids results in low blood volume inflow
and outflow. The onset of an erection is allowed by smooth
muscle relaxation and consequently a significant increase in
cavernosal arterial blood flow. The enlarging sinusoids com-
press the exiting venules and emissary veins, thereby pas-
sively restricting venous outflow. This situation of high inflow
with restricted outflow leads to an elevated intracorporal




Low-flow priapism, which accounts for more than 95% of all
priapic episodes, is a compartment syndrome at the level of
the corpora cavernosa and is characterized by a persistent
painful erection with little or absent inflow through the
cavernosal arteries.1 In the majority of cases, priapism is
idiopathic; blood dyscrasias, the use of recreational drugs
and alcohol abuse, malignancy, neurological diseases, and
intracavernosal injection of vasoactive drugs account for the
remaining 30 to 40% of episodes. As arterial inflow is reduced,
there are time-dependent changes in the corporal metabolic
environment that lead to progressive hypoxia, hypercarbia,
acidosis, and glucopenia. This causes a progressive damage to
the corporeal smooth muscle that becomes progressively
irreversible as ischemic time continues. Although it is still a
matter of debate as to the precise time when this process
becomes irreversible, intervention after 49 to 72 hours may
help relieve the pain and reverse the erection but will not be
able to reverse the necrosis of the smooth muscle. The
necrotic smooth muscle will be progressively substituted by
scar tissue, with consequent penile shortening and onset of
refractory erectile dysfunction. Therefore, low-flow priapism
is an emergency that requires immediate treatment, as any
delay in the management results in an increased risk of onset
of severe erectile dysfunction and penile shortening.8
Stuttering Priapism (Intermittent)
Stuttering priapism is a variant of low-flow priapism and
characterized by a pattern of recurrence. The term has
historically described recurrent, unwanted, and painful erec-
tions in men with sickle-cell disease. Patients typically are
awakened by erections that persist for less than 3 hours but
become progressively painful due to the onset of ischemia.
Unfortunately, males with sickle-cell disease may experience
stuttering priapism from childhood; in these patients, the
pattern of stuttering may increase in frequency and duration,
leading up to a full episode of unrelenting ischemic priapism.
Any patient who has experienced an episode of ischemic
priapism is also at risk for stuttering priapism.1
High-Flow Priapism (Nonischemic, Arterial)
High-flow priapism is a persistent erection caused by unregu-
lated cavernous arterial inflow. It wasfirst described by Burt et
al in 1960 when a man developed a persistent erection
following traumatic coitus.9 The high-flow etiology of pria-
pism is much less common than the low-flow condition, and
the etiology is largely attributed to trauma. It is typically the
result of injuries to the crura or corpora resulting in laceration
of the cavernous artery or one of its branches within the
corpora. This can be the result of either blunt or penetrating
injuries and include suchmechanisms as straddle injury, coital
trauma, kicks to the penis or perineum, pelvic fractures, birth
canal trauma to the newborn male, needle lacerations, com-
plications of penile diagnostics, vascular erosions complicating
metastatic infiltration of the corpora, and following surgical
interventions.10–12 In addition, high-flow priapism may arise
as a delayed complication of genital or perineal trauma
secondary to the development of an arteriocavernosal fistulas.
Any mechanism that lacerates a cavernous artery or
arteriole can produce unregulated pooling of blood in the
sinusoidal space with consequence erection, but the cavern-
ous environment does not become ischemic secondary to the
continuous influx of arterial blood.13 The corpora are tumes-
cent but not rigid, and patients do not complain of pain with
erection.1 In contrast to the low-flow condition, high-flow
priapism is not considered an emergent situation and does
not require immediate intervention.
Evaluation and Diagnosis of Priapism
History
High-flow priapism should be suspected when there is no
pain associated with the erection, the erection duration has
not been accompanied by progressive discomfort, and the
patient has a history as described earlier (►Table 1). The onset
of posttraumatic high-flowpriapismmay be delayed by hours
to days following the initial injury.1
Physical Exam
In low-flow priapism, the corpora cavernosa are rigid and
very tender to palpation.14 In patients with high-flow pria-
pism, there is minimal to no pain, and on exam the penis is
engorged or only partially erect.15 Depending on the location
Table 1 Clinical characteristics of priapism
High-flow priapism Low-flow priapism
Trauma history Yes No
Pain No Yes
Duration >4 h Any
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of the trauma and the elapsed time since the traumatic event,
there may be residual bruising and some tenderness on
palpation.
Laboratory Testing
Laboratory evaluation should include a complete blood count,
white blood cell with blood cell differential, platelet count,
and coagulation profile to assess for anemia, to rule out
infection and to detect hematologic abnormalities. Urine
and plasma toxicology should be performed if recreational
drugs are suspected from the psychosocial history. A corporal
blood gas analysis is recommended in the evaluation of
priapism in order to differentiate between low-flow and
high-flow priapism (►Table 2).
Color Doppler Ultrasonography
Color Doppler ultrasonography (CDU) is an adjunct to the
corporal blood aspirate in differentiating low-flow fromhigh-
flow priapism. CDU is performed using a high-frequency
transducer (7 MHz or higher). With the patient in the frog-
leg position and the scrotum elevated, the cavernosal arteries
are traced from their origin in the perineum along the ventral
aspect of the penile shaft. In low-flow priapism, cavernosal
arterial flow typically demonstrates a “high-resistance, low-
velocity” waveform and arterial flow is usually absent. In
high-flow priapism, CDU demonstrates a “low-resistance,
high-velocity” arterial waveform.4,16 The sensitivity of CDU
in localizing an arteriocavernosal fistula is nearly 100%.17 On
gray-scale ultrasonography, the arteriocavernosal fistula is a
hypoechoic area surrounded by echogenic tissue.
Magnetic Resonance Imaging
The use ofmagnetic resonance imaging (MRI) in the diagnosis
of priapism has not been well established, and MRI has a
limited role in the initial diagnosis given the emergency
situation of priapism. There has been at least one report of
MRI findings in four cases of high-flow priapism.18 In this
study, MRI demonstrated the arteriocavernosal fistula in all
patients. The authors of that article pointed out that while
CDU demonstrates characteristic flow patterns of priapism,
MRI has better potential in tissue characterization and dem-
onstration of a thrombus or arteriocavernosal fistula.18 Addi-
tional benefits of MRI include its ability to reliably predict
nonviable smoothmusclewithin the corpora after episodes of
priapism, as well as detecting unusual conditions such as
malignant infiltration.14
Treatment of High-Flow Priapism
Patients with high-flow priapism do not need to be managed
urgently because this does not result in ischemia within the
corpora cavernosa. Conservative management should be the
first-line treatment as there is a 60% chance of spontaneous
resolution.19 However, there is increasing clinical evidence
that long-standing, high-flow priapism could eventually lead
to cavernosal fibrotic changes and erectile dysfunction;
therefore, patients who do not respond to conservative
management may require more aggressive treatment.20,21
Conservative management consists of compression and
application of ice, with the aim of inducing vasospasm of
the cavernosal artery to facilitate clot formation and oblit-
eration of the fistula. If a cavernosal pseudoaneurysm is
identified on CDU, ultrasound-guided compression of the
pseudoaneurysm can be attempted.22 Intracavernosal
injection of α-adrenergic agonists (useful for the treatment
of the low-flow type) is not recommended for high-flow
priapism because of the different pathophysiology and
substantial risk of cardiovascular adverse effects.23
If conservative management is not successful, selective
embolization of the cavernosal artery can be attempted. This
method, first described by Wear et al in 1977, allows for
temporary occlusion of the cavernosal artery, thus permitting
cicatricial closure of the fistula and subsequent rechanneling
of the embolized artery.24 Recurrent or residual erectile
dysfunction after embolization treatment has been reported
in approximately 15 to 22% of high-flow priapism
patients.20,21,25,26
Several occlusive agents can be used for selective arterial
embolization, including autologous blood clot, gelatin
sponge, microcoils, polyvinyl alcohol, and glue. All of these
occlusive agents achieve a similar 75% resolution rate.13
Autologous blood clot, a temporary occlusive agent, has
been successfully used often in children in the embolization
of fistulas in the treatment of priapism.27,28 However, recur-
rence within a few hours has been reported, and the blood
clot can be technically more difficult to manipulate.29 Gelatin
sponge is a temporary occlusive agent that lasts 2 to 6 weeks
after being injected. Detumescence can be achieved with
gelatin sponge in theory without permanent vascular abla-
tion30 (►Fig. 1).
Microcoils are permanent occlusive agents. Hence, there
are theoretically increased risks of permanent vascular oc-
clusion and subsequent erectile dysfunction with their use.
Glue is an ionic permanent occlusive agent that polymerizes
when in contact with blood, and rapidly adheres to adjacent
tissues; extreme care must be taken during its use.29
In the literature, recurrence rates of 30 to 40% have been
reported for high-flow priapism treated by selective
embolization, explaining the frequent need for repeated
embolization.20
Surgical management with transcorporal fistula ligation is
reserved for cases where repeated embolization has failed, as
it carries a higher risk of future erectile dysfunction. Compli-
cations of surgical management include erectile dysfunction
(as high as 50%), penile gangrene, gluteal ischemia, purulent
cavernositis, and perineal abscess.31












pO2 > 90 mm Hg,
pCO2 < 40 mm Hg,
pH 7.40
pO2 < 30 mm Hg,
pCO2 > 60 mm Hg,
pH <7.25
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Priapism can be the result of a variety of etiologies and is often
a treatable condition. During the initial evaluation, it is
critical to differentiate high-flow and low-flow etiologies
because the pathophysiology and treatment are different.
Patients with low-flow priapism must be treated emergently
because of the high risk of complications. Patients with high-
flow priapism may be treated initially with conservative
therapy, reserving more aggressive treatments for those
patients who do not respond to conservative therapy. Selec-
tive transcatheter embolization of the arteriocavernosal
fistula with absorbable/nonabsorbable agents has been
shown to be effective, with the results of selective emboliza-
tion superior to surgical ligation with fewer complications.
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